Bryant Fong
Director/Board Member en JHL BIOTECH, INC. .
Fortuna: 224 968 $ al 31/03/2024
Perfil
Bryant E.
Fong is the founder of I2Dx, Inc. He currently holds multiple director positions at Alinea Pharmaceuticals, Inc., ADMA Biologics, Inc., WaveTec Vision Systems, Inc., Odyssey Thera, Inc., Neos Therapeutics, Inc., Eden Biologics, Inc.,.
Biomark Capital Management Co. LLC, Biozeus Biopharmaceutical SA, and FinHealth Gestão de Recursos SA. In the past, he served as a director at Acusphere, Inc., Pharmasset, Inc., Catalyst Bioscience, Inc., Cengent Therapeutics, Inc., TRF Pharma, Inc., Burrill LLC, Neurotech Pharmaceuticals, Inc. (United States), Logical Therapeutics, Inc., FerroKin BioSciences, Inc., and AliveCor, Inc. He was also the president of Nora Therapeutics, Inc. Mr. Fong obtained his undergraduate degree from the University of California, Berkeley in 1995.
Participaciones conocidas en empresas públicas
| Empresa | Fecha | Número de acciones | Valoración | Fecha de valoración |
|---|---|---|---|---|
ADMA BIOLOGICS, INC.
0.01% | 26/02/2024 | 34 086 ( 0.01% ) | 224 968 $ | 31/03/2024 |
Cargos activos de Bryant Fong
| Empresas | Cargo | Inicio |
|---|---|---|
| NEOS THERAPEUTICS, INC. | Director/Board Member | 15/06/2009 |
| ADMA BIOLOGICS, INC. | Director/Board Member | 01/05/2012 |
| JHL BIOTECH, INC. | Director/Board Member | 17/12/2012 |
FinHealth Gestão de Recursos SA
 FinHealth Gestão de Recursos SA Investment ManagersFinance FinHealth Gestão de Recursos SA (FinHealth) an independent private equity and venture capital firm headquartered in Rio de Janeiro, Brazil. It was founded in 2010. | Private Equity Investor | 01/01/2014 |
Biozeus Biopharmaceutical SA
 Biozeus Biopharmaceutical SA Miscellaneous Commercial ServicesCommercial Services Biozeus Biopharmaceutical SA operates as a drug development company. It engages in the identifying early-stage drug candidates from Brazilian research institutions and develop them into new therapies for improving and saving lives, worldwide. The company is headquartered in Rio de Janeiro, Brazil. | Director/Board Member | - |
WaveTec Vision Systems, Inc.
 WaveTec Vision Systems, Inc. Electronic ComponentsElectronic Technology WaveTec Vision Systems, Inc. develops and provides wavefront measurement technologies. It focuses on research, development, manufacturing, and distribution of the Optiwave Refractive Analysis (ORA) system with VerifEye used during cataract surgery. The firm offers ophthalmic medical devices. The company was founded by Kenneth C. Aldrich, William B. Adams, Thomas J. Berryman, and Tony Van Heugten in 1997 and is headquartered in Aliso Viejo, CA. | Director/Board Member | - |
I2Dx, Inc.
 I2Dx, Inc. Packaged SoftwareTechnology Services I2Dx, Inc. Develops diagnostic platform for the assessment of prodromal Alzheimer’s disease. The company was founded by Janos Redei and is headquartered in Palo Alto, CA. | Founder | - |
Biomark Capital Management Co. LLC
 Biomark Capital Management Co. LLC Investment ManagersFinance Biomark Capital Management Co. LLC (Biomark Capital) is a private equity and venture capital firm founded in 2011. The firm is headquartered in Greenwich, Connecticut. | Private Equity Investor | 01/11/2013 |
Alinea Pharmaceuticals, Inc.
 Alinea Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Alinea Pharmaceuticals, Inc. is a biopharmaceutical company focused on developing new therapeutics for the treatment of diabetes and metabolic disorders. The company was founded in August 2005 and is headquartered in Cambridge, MA. | Director/Board Member | - |
| ░░░░░░░ ░░░░░░ ░░░░ | ░░░░░░░░░░░░░░ ░░░░░░ | - |
Antiguos cargos conocidos de Bryant Fong.
| Empresas | Cargo | Fin |
|---|---|---|
| ░░░░░░░ ░░░░░░░░░ ░░░░ | ░░░░░░░░░░░░░░ ░░░░░░ | ░░░░░░░░░░ |
| ░░░░░░░ ░░░ | ░░░░░░░ ░░░░░░ ░░░░░░░░ | ░░░░░░░░░░ |
| ░░░░░░░ ░░░░░░░░░░░░░ ░░░░ | ░░░░░░░░░░░░░░ ░░░░░░ | - |
| ░░░░░░░░░░░ ░░░░ | ░░░░░░░░░░░░░░ ░░░░░░ | - |
| ░░░ ░░░░░░░ ░░░░ | ░░░░░░░░░░░░░░ ░░░░░░ | - |
Formación de Bryant Fong.
| University of California, Berkeley | Undergraduate Degree |
Experiencias
Funciones ocupadas
Activas
Inactivas
Empresas cotizadas
Empresas privadas
Relaciones
Relaciones de 1er grado
Empresas vinculadas al 1er grado
Hombre
Mujer
Administradores
Ejecutivos
Empresas relacionadas
| Empresas cotizadas | 2 |
|---|---|
| ACUSPHERE, INC. | Health Technology |
| ADMA BIOLOGICS, INC. | Health Technology |
| Empresas privadas | 20 |
|---|---|
Pharmasset, Inc.
 Pharmasset, Inc. Pharmaceuticals: OtherHealth Technology Pharmasset, Inc. developed drugs to treat viral infections. It focued in the development of oral therapeutics for the treatment of hepatitis C virus (HCV) infection. The company was founded in 1998 and was headquartered in Princeton, NJ. | Health Technology |
Catalyst Bioscience, Inc. /Old/
 Catalyst Bioscience, Inc. /Old/ Medical SpecialtiesHealth Technology Catalyst Bioscience, Inc. develops and markets catalytic biopharmaceutical products. Its technology consists of methods to identify proteases with tailor-made specificity or improved pharmacological properties. The company was founded by Charles Craik, Sandra Waugh Ruggles and Christopher Thanos in 2003 and is headquartered in South San Francisco, CA. | Health Technology |
Cengent Therapeutics, Inc.
 Cengent Therapeutics, Inc. Miscellaneous Commercial ServicesCommercial Services Cengent Therapeutics, Inc. used to research and develop pharmaceutical drugs. It was a structure-based drug discovery company with a primary focus on compounds targeting signal transduction for the treatment of obesity and diabetes. It used to discover orally active PTP-1B inhibitors for treatment of type II diabetes and obesity. It was headquartered in San Diego, CA. | Commercial Services |
Alinea Pharmaceuticals, Inc.
Alinea Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Alinea Pharmaceuticals, Inc. is a biopharmaceutical company focused on developing new therapeutics for the treatment of diabetes and metabolic disorders. The company was founded in August 2005 and is headquartered in Cambridge, MA. | Health Technology |
WaveTec Vision Systems, Inc.
WaveTec Vision Systems, Inc. Electronic ComponentsElectronic Technology WaveTec Vision Systems, Inc. develops and provides wavefront measurement technologies. It focuses on research, development, manufacturing, and distribution of the Optiwave Refractive Analysis (ORA) system with VerifEye used during cataract surgery. The firm offers ophthalmic medical devices. The company was founded by Kenneth C. Aldrich, William B. Adams, Thomas J. Berryman, and Tony Van Heugten in 1997 and is headquartered in Aliso Viejo, CA. | Electronic Technology |
TRF Pharma, Inc.
 TRF Pharma, Inc. Pharmaceuticals: MajorHealth Technology TRF Pharma, Inc. develops pharmaceutical products. It specializes in the fields of hematology and oncology. The firm's services include developing therapies to treat diseases related to aberrant cell adhesion and endothelial walls. The company was founded by Stephen H. Embury and Neil Matsui in 2002 and is headquartered in Burlingame, CA. | Health Technology |
Burrill LLC
 Burrill LLC Investment ManagersFinance Burril LLC (Burrill) is a private equity/venture capital firm founded in 1994 by G. Steven. The firm is headquartered in San Francisco, California. | Finance |
Neurotech Pharmaceuticals, Inc. (United States)
 Neurotech Pharmaceuticals, Inc. (United States) Pharmaceuticals: MajorHealth Technology Neurotech Pharmaceuticals, Inc. designs and develops therapeutic systems for retinal diseases. The company was founded in 1995 and is headquartered in Cumberland, RI. | Health Technology |
Odyssey Thera, Inc.
 Odyssey Thera, Inc. Pharmaceuticals: MajorHealth Technology Odyssey Thera, Inc. operates as a biopharmaceutical company. The company was founded by John Westwick and Stephen W. Michnick in 2000 and is headquartered in San Ramon, CA. | Health Technology |
Neos Therapeutics, Inc.
 Neos Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Neos Therapeutics, Inc is a pharmaceutical company focused on developing, manufacturing and commercializing products utilizing its proprietary modified-release drug delivery technology platforms. Its products are Adzenys XR-ODT (amphetamine), Cotempla XR-ODT (methylphenidate), and Adzenys-ER (amphetamine) extended-release oral suspension, all for the treatment of ADHD, are the first three approved products using the Company's extended-release technology platform. The firm manufactures and markets its generic version of the branded product Tussionex, an extended-release oral suspension of hydrocodone and chlorpheniramine for the relief of cough and upper respiratory symptoms of a cold. The company was founded by Darlene R. Ryan on November 30, 1994 and is headquartered in Grand Prairie, TX. | Health Technology |
Logical Therapeutics, Inc.
 Logical Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Logical Therapeutics, Inc. develops products that treat diseases associated with inflammation. It provides a platform of bio-activated prodrugs for the chronic treatment of arthritis. Its bio-activated NSAID prodrugs are chemical entities that are designed to reduce the incidence of GI ulcers and improve GI tolerability in patients who require chronic NSAID treatment. The company was founded by Carolyn E. Green in 2005 and is headquartered in Waltham, MA. | Health Technology |
FerroKin BioSciences, Inc.
 FerroKin BioSciences, Inc. Pharmaceuticals: MajorHealth Technology FerroKin BioSciences, Inc. offers clinical stage biotechnology services for iron chelator in the treatment of iron-overload in patients with transfusion-dependent hereditary and acquired refractory anemia. The company was founded by Hugh Young Rienhoff, Jr. in 2007 and is headquartered in San Carlos, CA. | Health Technology |
Nora Therapeutics, Inc.
 Nora Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Nora Therapeutics, Inc. develops therapeutics to address clinical unmet needs in reproductive medicine. Its's lead product NT100, seeks to improve pregnancy outcomes in women undergoing in vitro fertilization or who have suffered recurrent spontaneous miscarriages. The company was founded by Darryl L. Carter and Chris B. McClain in 2007 and is headquartered in Palo Alto, CA. | Health Technology |
AliveCor, Inc.
 AliveCor, Inc. Packaged SoftwareTechnology Services AliveCor, Inc. develops mobile heart monitoring system. It offers kardia mobile that provides people with suspected or diagnosed heart conditions, and those at risk of heart conditions. The company was founded by David E. Albert, Bruce Satchwell, and Kim Barnett and is headquartered in San Francisco, CA. | Technology Services |
Eden Biologics, Inc.
 Eden Biologics, Inc. Pharmaceuticals: MajorHealth Technology Eden Biologics, Inc. is engaged in the manufacture and sale of bio-pharmaceuticals products. It offers cell line cloning, antibody cloning, monoclonal antibody, cell line development, master and working cell banks, cell culture process development, purification process development, formulation development, and analytical assays. The company was founded on June 14, 2012 and is headquartered in Zhupei, Taiwan. | Health Technology |
Biomark Capital Management Co. LLC
Biomark Capital Management Co. LLC Investment ManagersFinance Biomark Capital Management Co. LLC (Biomark Capital) is a private equity and venture capital firm founded in 2011. The firm is headquartered in Greenwich, Connecticut. | Finance |
I2Dx, Inc.
I2Dx, Inc. Packaged SoftwareTechnology Services I2Dx, Inc. Develops diagnostic platform for the assessment of prodromal Alzheimer’s disease. The company was founded by Janos Redei and is headquartered in Palo Alto, CA. | Technology Services |
Biozeus Biopharmaceutical SA
Biozeus Biopharmaceutical SA Miscellaneous Commercial ServicesCommercial Services Biozeus Biopharmaceutical SA operates as a drug development company. It engages in the identifying early-stage drug candidates from Brazilian research institutions and develop them into new therapies for improving and saving lives, worldwide. The company is headquartered in Rio de Janeiro, Brazil. | Commercial Services |
FinHealth Gestão de Recursos SA
FinHealth Gestão de Recursos SA Investment ManagersFinance FinHealth Gestão de Recursos SA (FinHealth) an independent private equity and venture capital firm headquartered in Rio de Janeiro, Brazil. It was founded in 2010. | Finance |
Deep Medicine Acquisition Corp.
 Deep Medicine Acquisition Corp. Financial ConglomeratesFinance Deep Medicine Acquisition Corp. is a blank check company, which aims on effecting a merger, capital stock exchange, asset acquisition, stock purchase, reorganization or similar business combination with one or more businesses. The company was founded on July 8, 2020 and is headquartered in New York, NY. | Finance |
- Bolsa de valores
- Insiders
- Bryant Fong
